technology-driven monitoring.
Mezoo is a digital healthcare company developing ambulatory Remote Patient Monitoring (aRPM)
solutions to eliminate monitoring blind spots in clinical settings.
By continuously collecting and transmitting patients’ biometric data, Mezoo enables earlier detection of
condition changes and addresses structural challenges such as monitoring gaps, clinical workload, and
limited real-time response outside hospitals. Through advanced wearable technology and data analytics,
Mezoo is building a sustainable patient monitoring environment that connects care inside and outside
the hospital while addressing unmet medical needs.
Vision
Reliable data, human-centered technology, and innovation that leads global standards.
Our research institute is built on the core values of reliable data, human-centered technology, and innovation that defines global standards.
Patient safety and quality of life: by providing solutions that accurately monitor patients’ health anytime, anywhere, we support early diagnosis and maximize treatment effectiveness.
Our institute will continue to challenge and innovate to build a future-oriented healthcare ecosystem that both clinicians and patients can rely on.
We provide solutions that enable accurate monitoring of patient health anytime and anywhere, contributing to early diagnosis and maximized therapeutic outcomes.
We build differentiated healthcare platforms that combine multi-biosignal data such as ECG, oxygen saturation, and body temperature with on-device machine learning and AI analytics.
We aim to grow into a global digital healthcare leader by developing internationally recognized research outcomes and standardized medical devices beyond the domestic market.
Key research areas and achievements
Milestones that prove meaningful change through technology.| 연월 | 내용 |
|---|---|
| 2025년 02월 | HiCardi + 브라질 의료기기 등록(ANVISA) |
| 2025년 01월 | 산업부, 시장주도형 K-센서 기술개발사업 수행 |
| 2024년 12월 | 가속도 데이터를 이용한 행동 분석 장치 및 방법 KR 2024-0197612 출원 |
| 2024년 10월 | HiCardi + 호주 의료기기 등록(ARTG) |
| 2024년 09월 | HiCardi + H100 FDA 승인(510(k)) |
| 2024년 08월 | HiCardi +를 활용한 Inpatient Monitoring System 구축사업 기술지원 확약(PNT, 메쥬) |
| 2024년 07월 | 심전도 유도 안내 시스템 및 방법 JP 7512554 등록 |
| 2024년 06월 | 학술 연구 사업 및 공동 제품 개발을 목표로 연구 업무 협약 체결(AITRICS, 메쥬) |
| 2024년 04월 | HiCardi + H100 일본 의료기기 등록(PMDA) |
| 2024년 03월 | HiCardi + 사우디아라비아 의료기기 등록(SFDA) |
